Growth hormone interferes with the progression of myocarditis in rats.

[1]  Z. Zong,et al.  Involvement of protein kinase C in taxol-induced polyploidization in a cultured sarcoma cell line. , 2000, European journal of pharmacology.

[2]  A. Matsumori,et al.  Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. , 1999, Circulation.

[3]  Beranek Jt.  Why growth hormone therapy is efficient in heart failure , 1999 .

[4]  T. Voigtländer,et al.  Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. , 1999, Circulation.

[5]  J. Ross.  Growth hormone, cardiomyocyte contractile reserve, and heart failure. , 1999, Circulation.

[6]  B. Lorell,et al.  Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. , 1999, Circulation.

[7]  M. Lindsey,et al.  Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. , 1998, Circulation.

[8]  M. Lindsey,et al.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. , 1998, Circulation.

[9]  M. Kodama,et al.  Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. , 1998, Circulation research.

[10]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[11]  M. Dardenne,et al.  Growth hormone stimulates the proliferation of activated mouse T lymphocytes. , 1997, Endocrinology.

[12]  S. Goto,et al.  Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. , 1997, Journal of molecular and cellular cardiology.

[13]  A. Matsumori,et al.  Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. , 1996, Circulation.

[14]  J. Penninger,et al.  Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[15]  B. Biondi,et al.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.

[16]  Z. Zong,et al.  Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. , 1996, Biochemical and biophysical research communications.

[17]  Y. Seko,et al.  Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. , 1995, The Journal of clinical investigation.

[18]  R. Clark,et al.  Growth hormone improves cardiac performance in experimental heart failure. , 1995, Circulation.

[19]  M. Kodama,et al.  Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. , 1995, Circulation research.

[20]  H. Turner,et al.  Regulation of the Adapter Molecule Grb2 by the FcR1 in the Mast Cell Line RBL2H3 (*) , 1995, The Journal of Biological Chemistry.

[21]  M. Kodama,et al.  Effects of 15-deoxyspergualin on experimental autoimmune giant cell myocarditis of the rat. , 1995, Circulation.

[22]  J. Ross,et al.  Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. , 1995, The Journal of clinical investigation.

[23]  M. Kodama,et al.  Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. , 1994, Circulation research.

[24]  P. Jensen,et al.  THE ABSENCE OF CONSTITUTIVE AND INDUCED EXPRESSION OF CRITICAL CELL‐ADHESION MOLECULES ON HUMAN CARDIAC MYOCYTES: ITS ROLE IN TRANSPLANT REJECTION1,2 , 1994, Transplantation.

[25]  L. Saccá,et al.  Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. , 1993, The Journal of clinical endocrinology and metabolism.

[26]  C. Carella,et al.  Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. , 1993, The Journal of clinical endocrinology and metabolism.

[27]  K. Sell,et al.  Immunologic dialogue between cardiac myocytes, endothelial cells, and mononuclear cells. , 1993, Clinical immunology and immunopathology.

[28]  D. Longo,et al.  Differential effects of growth hormone and prolactin on murine T cell development and function , 1993, The Journal of experimental medicine.

[29]  K. Sell,et al.  Host T-cell primary allosensitization to MHC class-I- and class-II-expressing human cardiac myocytes requires the presence of a second signal. , 1993, Human immunology.

[30]  K. Sell,et al.  Major histocompatibility complex-expressing human cardiac myocytes are not the direct target of host cardiac-infiltrating cells: evidence for a prominent role of the indirect pathway in human cardiac allograft rejection. , 1993, Transplantation proceedings.

[31]  D. Longo,et al.  Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. , 1992, Journal of immunology.

[32]  P. Allen,et al.  Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Sell,et al.  Indirect presentation of donor histocompatibility antigens contributes to the allogeneic response against human cardiac myocytes. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  P. Allen,et al.  Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. , 1992, Circulation research.

[35]  S. Galli,et al.  Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses , 1991, The Journal of experimental medicine.

[36]  Y. Lecarpentier,et al.  Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. , 1990, The Journal of clinical investigation.

[37]  S. Galli,et al.  Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin , 1990, Nature.

[38]  D. Rudman,et al.  Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.

[39]  S. Galli,et al.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.

[40]  C. Heusser,et al.  Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation , 1989, Nature.

[41]  W. Paul,et al.  Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.

[42]  P. Sönksen,et al.  CARDIAC FAILURE RESPONDING TO GROWTH HORMONE , 1989, The Lancet.

[43]  K. Kelley,et al.  Growth hormone, lymphocytes and macrophages. , 1989, Biochemical pharmacology.

[44]  J. Jansson,et al.  Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. , 1988, Endocrinology.

[45]  K. Sell,et al.  MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I AND CLASS II EXPRESSION BY MYOCYTES IN CARDIAC BIOPSIES POSTTRANSPLANTATION , 1988, Transplantation.

[46]  J. D. Young,et al.  Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Paul,et al.  B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells , 1987, Cell.

[48]  C. Eaves,et al.  Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. , 1986, Blood.

[49]  M. Yacoub,et al.  Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. , 1986, Transplantation.

[50]  P. Baker,et al.  Giant cell myocarditis. , 1985, The American journal of medicine.

[51]  S. Fuggle,et al.  THE DETAILED DISTRIBUTION OF HLA‐A, B, C ANTIGENS IN NORMAL HUMAN ORGANS , 1984, Transplantation.

[52]  D. Golde,et al.  Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. , 1981, Blood.

[53]  E. C. Snow,et al.  The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. , 1981, Journal of immunology.

[54]  M. Kodama,et al.  Analysis of heart-infiltrating T-cell clonotypes in experimental autoimmune myocarditis in rats. , 1996, Circulation research.

[55]  J. Isgaard,et al.  Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle. , 1989, The Journal of endocrinology.

[56]  J. Roth,et al.  Effects of growth hormone on the adult canine thymus. , 1987, Thymus.